Internal Reference Number: FOI_6409
Date Request Received: 21/12/2021 00:00:00
Date Request Replied To: 22/12/2021 00:00:00
This response was sent via: By Email
Request Summary: Analysing the incidence and treatment of Haemophilia A
Request Category: Companies
Question Number 1: How many haemophilia A patients are registered with your centre, and how many of these patients are classified as exhibiting mild, moderate, or severe disease. | |
Answer To Question 1: Section 38 refusal notice applied | |
Question Number 2: In the last three months, how many patients have been treated by your haemophilia centre with the following products? • Advate • Adynovi • Elocta • Esperoct • Factor Eight Inhibitor Bypass Activity (FEIBA) • Hemlibra • NovoEight • NovoSeven RT • Obizur • Refacto AF | |
Answer To Question 2: Section 38 refusal notice applied | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.